Fetal and neonatal hyperthyroidism

Thyroid

Volumn 9, Issue 7, 1999, Pages 727-733

  Zimmerman, Donald ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; GLUCOCORTICOID; IODINE; IOPANOIC ACID; IOPODATE SODIUM; LUGOL; POTASSIUM IODIDE; PREDNISONE; PROPRANOLOL; PROPYLTHIOURACIL; THYROTROPIN RECEPTOR;

CONFERENCE PAPER; CORDOCENTESIS; CRANIOFACIAL SYNOSTOSIS; ECHOGRAPHY; FETUS; FETUS DEATH; FETUS HYDROPS; GENE MUTATION; HUMAN; HYPERTHYROIDISM; INTRAUTERINE GROWTH RETARDATION; NEWBORN; PRIORITY JOURNAL; THYROIDECTOMY;

EID: 0032783726     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1999.9.727     Document Type: Conference Paper

References (98)

1. Ochsner AJ, Thompson RL 1910 The Surgery and Pathology of the Thyroid and Parathyroid glands. CV Mosby Co., St. Louis, p 192.
2. White C 1912 A fetus with congential hereditary Graves' disease. Obstet Gynecol Br Comm 21:231-233.
3. McKenzie JM 1964 Neonatal Graves' disease. Clin Endocrinol Metal 24:660.
4. Nutt J, Clark S, Welch PG, Hall R 1974 Neonatal hyperthyroidism and long-acting thyroid stimulator protector. Br Med J 2:695-696.
5. Dirmikis SM, Munro DS 1975 Placental transmission of thyroid-stimulating immunoglobulin. Br Med J 2:665-666.
6. Yoshimoto M, Nakayama M, Baba T, Uehara Y, Niikawa N, Ito M, Tfuji Y 1991 A case of neonatal McCune-Albright syndrome with Cushing syndrome and hyperthyroidism. Acta Paediatr Scand 80:984-987.
7. Spiegel Am 1997 The molecular basis of disorders caused by defects in G protein [review]. Horm Res 47:89-96.
8. Kopp P, Van Sande J, Parma J, Duprez L, Gerber H, Joss E, Jameson JL, Dumont JE, Vassart G 1995 Brief report: Congenital hyperthyroidism caused by a mutation in the thyrotropin receptor gene. N Engl J Med 322:150-154.
9. Wing DA, Millar LK, Koonings PP, Montoro MN, Mestman JH 1994 A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol 170:90-95.
10. Kamijo K, Saito T, Saito M, Yachi A, Mokai A, Fukusi M, Takasugi N 1990 Transient subclinical hyperthyroidism in early pregnancy. Endocrinol Japon 37:397-403.
11. Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH 1994 Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Am J Obstet Gynecol 84:946-949.
12. Mortimer RH, Tyack SA, Galligan JP, Perry-Keene DA, Tan YM 1990 Graves' disease in pregnancy: TSH receptor binding inhibiting immunoglobulins and maternal and neonatal thyroid function. Clin Endocrinol 32:141-152.
13. Tamaki H, Amino N, Takeoka K, Iwatani Y, Tachi J, Kimura M, Mitsuda N, Miki K, Nose O, Tonizawa O 1989 Prediction of later development of thyrotoxicosis or central hyporthyroidism from the cord serum thryoid-stimulating hormone level of neonates born to mothers with Graves' disease. J Pediatr 115:318-321.
14. Cove DH, Johnston P 1985 Fetal hyperthyroidism: Experience of treatment in four siblings. Lancet 1:430-432.
15. Check JH, Rezvani I, Goodner D, Hopper B 1982 Prenatal treatment of thyrotoxicosis to prevent intrauterine growth retardation. Obstet Gynecol 60:122-124.
16. Polak M, Leger J, Luton D, Oury JF, Voillard E, Boissinot C, Czernichow P 1997 Fetal cord blood sampling in the diagnosis and the treatment of fetal hyperthyroidism in the off-spring of the euthyroid mother producing thyroid-stimulating immunoglobulins. Ann Endocrinol 58:338-342.
17. Watson WJ, Flegen MM 1995 Fetal thyrotoxicosis associated with nonimmune hydrops. M J Obstet Gynecol 172: 1039-1040.
18. Lao TT, Chin RK, Chan A 1988 Transient hyperthyroidism in a pregnancy with hydrops fetalis. Case Report. Br J Obstet Gynecol 95:624-625.
19. Sarrehi C 1968 Accelerated maturity in fetal thyrotoxicosis. Clin Pediatr 7: 134-137.
20. Utiger RD 1991 Recognition of thryoid disease in the fetus. N Engl J Med 324:559-561.
21. Cove DH, Johnston P 1985 Fetal hyperthyroidism: the experience of treatment in four siblings. Lancet 1:430-432.
22. Maxwell KD, Kearney KK, Johnson JW, Eagan JW Jr, Tyson JE 1980 Fetal tachycardia associated with intrauterine fetal thyrotoxicosis. Obstet Gynecol 55(Suppl):18s-22s.
23. Wallace C, Couch R, Ginsberg J 1995 Fetal thyrotoxicosis: A case report and recommendations for prediction, diagnosis, and treatment. Thyroid 5:125-128.
24. Meden H, Rath W 1989 Kongenitale Hyperthyroste bei maternalem Morbos Basedow. Gedurt und Faraunenheilkunde 49:822-824.
25. Riggs W Jr, Wilroy RS Jr, Etteldorf JN 1972 Neontal hyperthyroidism with accelerated skeletal maturation, cranio-synostosis, and brachydactyly. Radiology 105:621-625.
26. Schwab KO, Söhlemann P, Gerlich M, Von Petrykowski W, Holzapfel HP, Paschke R, Gruters A, Denvahl M 1996 Mutations of the TSH receptor as a cause of congenital hyperthyroidism. Exp Clin Endocrinol Diabetes Suppl 4:124-128.
27. Thibault H, Breton D, Brauner R 1993 Hyperthyroidie neonatale transitoire par transfert trans placentaire d' antscorps antirecepturs de la thyreostimuline hypophysaire. Arch Francaises Pediatr 50:581-583.
28. Daneman D, Howard NK 1980 Neonatal thyrotoxicosis: intellectual impairment and craniosynostosis in later years. J Pediatr 97:257-259.
29. Landier F, Foucaud P, Thomasin N, Chaussain JL, Job JC 1983 Maladie de Basedow neonatale avec craniosynostose premature et stenose de l'aqueduc de Sylvius. Arch Francaises Pediatr 40:727-729.
30. Hollingsworth DR, Mabry CC 1976 Congenital Graves' disease. Four familial cases with long-term follow-up and perspective. Am J Dis Child 130:148-155.
31. Davis LE, Lucus MJ, Hankins JDB, Raark ML, Cunningham FG 1989 Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 160:63-70.
32. Yoshimoto M, Nakayama HOC, Baba P, Uehara Y, Niikawa N, Ito M, Tsuji Y 1991 A case of neonatal McCune-Albright syndrome with Cushing syndrome and hyperthyroidism. Acta Pediatr Scand 89:984-987.
33. Pare C, Demers PP 1972 Hyperthyroidie neonatle insuffisance cardiaque et LAT Union Medscal due Canada 101:1307-1310.
34. Riopel DA, Mullins CE 1972 Congenital thyrotoxicosis with paroxysmal atrial tachycardia. Pediatrics 50:140-144.
35. Shapiro S, Steier M, Dimich I 1975 Congestive heart failure in neonatal thyrotoxicosis. A curable cause of heart failure in the newborn. Clin Pediatr 14:1155-1156.
36. Farrehi C, Mitchell M, Fawcett EM 1966 Heart failure in congenital thyrotoxicosis. Pediatrics 37:460-466.
37. Eason E, Costom E, Papageorgiou AN 1982 Hypertension in neonatal thyrotoxicosis. J Pediatr 100:766-781.
38. O'Donovan D, McMahon C, Costigan C, Oslizlok P, Guss D 1997 Reversible pulmonary hypertension in neonatal Graves' disease. Irish Med J 90:147-148.
39. Skelton MO, Gans B 1955 Congenital thyrotoxicosis, hepatosplenomegaly and jaundice in two infants of exophthalmic mothers. Arch Dis Child 90:460.
40. Bussman YL, Tillman ML, Phliara AS 1977 Neonatal thyrotoxicosis associated wtih the hyperviscosity syndrome. J Pediatr 90:266-268.
41. Zaidi AH 1965 Congential thyrotoxicosis with hepato-splenomegaly and thrombocytopenia associated with aniridia and dislocated lenses. Proc R Soc Med 58:390.
42. 131iodine uptake studies. J Endocrinol 41:299-300.
43. Javett SN, Senior B, Bravdo JL, Heymann S 1959 Neonatal thyrotoxicosis. Pediatrics 24:65.
44. Rosenberg D, Grand MJH, Silbert D 1963 Neonatal hyperthyroidism. N Engl J Med 268:292.
45. Velsar HL, Foley TT Jr, Hill LM, Kislak S 1991 Sonographic findings in maternal fetal hyperthyroidism/fetal goiter. J Ultrasound Med 10:281-284.
46. Samsamy B, Jethwa AK, Ferriman D 1970 Congenital thyrotoxicosis. Proc R Soc Med 63:577-578.
47. De Roux N, Polak M, Coet J 1996 A neomutation of the thyroid stimulating hormone receptor in severe neonatal hyperthyroidism. J Clin Endocrinol Metab 81:2023-2026.
48. Nevard CHF, Gaunt M, Ockleford CD 1990 The transfer of "passive and active immunity." In: Chaovat G, ed. The Immunology of the Fetus. CRC Press, Inc. Boca Raton pp 193-214.
49. Amino N, Tada H, Hidaka Y 1996 Autoimmune thyroid disease and pregnancy [review]. J Endocrinol Invest 19:59-70.
50. Munro DS, Dirmikis SM, Humphies H, Smith T 1978 The role of thyroid-stimulating immunoglobulins of Graves' disease in neonatal thyrotoxicosis. Br J Obstet Gynecol 85:837-843.
51. Zakarija M, McKenzie JM 1983 Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism. J Clin Endocrinol Metal 57:1036-1040.
52. Mortemer RH, Tiak SA, Gallagan JP, Perry-Keene DA, Tan YM 1990 Graves' disease in pregnancy: TSH receptor binding inhibiting immunoglobulin and maternal and neonatal thyroid function. Clin Endocrinol 32:141-152.
53. McKinzie JM, Zakarijia M 1992 Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid 2:155-160.
54. Mitsuda N, Tamaki H, Amino N, Hosono T, Miyai K, Tanizawa O 1992 Risk factors for development disorders in infants born to women with Graves' disease. Obstet Gynecol 80:359-364.
55. Mejia-Heredin A, Litchfield WR, Zurakowski D, Ceely EW, Majzoub JA 1995 Assessing the risk of neonatal Graves' disease using TSI measurements [abstract P3-460]. 77th Annual Meeting of the Endocrine Society, Washington, DC.
56. O'Hearlihy C 1977 Neonatal thyrotoxicosis with long-acting thyroid-stimulator protector. Irish Med J 70:124-125.
57. Zakarija M, McKenzie JM, Munro CS 1983 Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves' disease. J Clin Invest 72:1352-1356.
58. Sunshine P, Kusumoto H, Kriss JP 1965 Survival time of circulating long-acting thyroid stimulator in neonatal thyrotoxicosis: Implications for diagnosis and therapy of the disorder. Pediatrics 36:869.
59. Skuza KA, Sills IN, Stene M, Rapaport R 1996 Prediction of neonatal hyperthyroidism in infants born to mothers with Graves' disease. J Pediatr 128:264-267.
60. Schwab KO, Gerlich M, Broacker M, Sohlemann P, Derwahl M, Lohse MJ 1997 Constitutively active germline mutation of the thyrotropin receptor gene as a cause of congenital hyperthyroidism. J Pediatr 131:899-904.
61. Fuhrer D, Wonelw P, Willgerodt H, Paschke R 1997 Identification of a new thyrotropin receptor germline mutation (leu629 phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism. J Clin Endocrinol Metab 82:4234-4238.
62. Holzatsel HP, Wonrow P, Don Petrykowski W, Henschen M, Schervaun WA, Paschke R 1997 Sporadic congenital hyperthyroidism due to a spontaneous germline mutation in the thyrotropin receptor gene. J Clin Endocrinol Metab 82: 3879-3884.
63. Thomas SL, Leclere J, Hartemann P, Duheille J, Orgiazzi J, Petersen M, Janot C, Guedenet JC 1982 Familial hyperthyroidism without evidence of autoimmunity. Acta Endocrinol 100:512-518.
64. Duprez L, Parma J, Van Sande J, Allgeier A, Leclere J, Schvartz C, Delisle MJ, Decoulx M, Orgiazzi J, Dumont J 1994 Germline mutations in the thyrotropin receptor gene cause non-autosomal dominant hyperthyroidism. Nat Genet 7:396-401.
65. 2. J Pediatr 93:119-120.
66. Scrup J, Petersen S 1979 Fetal thyrotoxicosis in utero. Biol Neonate 35:175-179.
67. Thompson JA, Riley ID 1966 Neonatal thyrotoxicosis associated with maternal hyperthyroidism. Lancet 1:635-636.
68. Wit JM, Gerards LJ, Vermeulen-Meiners C, Bruinse HW 1985 Neonatal thyrotoxicosis treated wtih exchange transfusion and Lugol's iodine. Eur J Pediatr 143:317-319.
69. Zakarija M, McKenzie JM, Hoffmann WH 1986 Prediction and therapy of intrauterine and late-onset neonatal hyperthyroidism. J Clin Endocrinol Metab 62:368-371.
70. Bolpe R, Ehrlich R, Steiner G, Row VP 1984 Graves' disease in pregnancy years after hypothyroidism with recurrent passive-transfer neonatal Graves' disease in offspring. Am J Med 77:572-578.
71. Wanstrom KD, Weiner CP, Williamson I, Grant SS 1990 Prenatal diagnosis of fetal hyperthyroidism using funipuncture. Obstet Gynecol 76:513-517.
72. Ghidini A, Sepulzeda W, Lockwood CJ, Glomero R 1993 Complications of fetal blood sampling. Am J Obstet Gynecol 168:1339-1344.
73. Petrikovsky B 1997 Complications after cordocentesis appear excessive. Am J Obstet Gynecol 177:1567.
74. Luton D, Fried D, Sibony D, Vuillard E, Tebeka B, Boissinot C, Leger J, Polak M, Oury JF, Blot P 1997 Assessment of fetal thyroid function by a colored Doppler echography. Fetal Diagn Ther 12:24-27.
75. Castagnone D, Rivolta R, Rescalli S, Baldini MI, Tozzi R, Contalamessa L 1996 Color Doppler signal in Graves' disease: Value in assessing activity of disease and predicting outcome. AJR 166:203-207.
76. Chopra IJ 1992 Fetal and neonatal hyperthyroidism. Thyroid 2:161-163.
77. Fisher DA 1996 Disorders of the thyroid in the newborn and infant. In: Sperling MA, ed. Pediatric Endocrinology, W.B. Saunders, Philadelphia, pp 51-70.
78. Burgi H, Wimpsheimer C, Burger A, Zaunbauer W, Rosler H, Lemarchand-Beraud T 1976 Changes of circulating thyroxine, triiodothyronine, and reverse triiodothyronine after radiographic contrast agents. J Clin Endocrinol Metab 43:1203-1210.
79. Karpman BA, Rappoport B, Filetti F, Fisher DA 1987 Treatment of neonatal hyperthyroidism due to Graves' disease with sodium ipodate. J Clin Endocrinol Metab 64:119-123.
80. Transue D, Chan J, Kaplan N 1992 Management f neonatal Graves' disease with iopanoic acid. J Pediatr 121:472-474.
81. Joshi R, Kulin HE 1993 Treatment of neonatal Graves' disease with sodium ipodate. Clin Pediatr 32:181-184.
82. Pemberton PJ, McConnell B, Shanks RG 1974 Neonatal thyrotoxicosis treated with propranolol. Arch Dis Child 49:813-815.
83. Pearl KN, Chambers TI 1977 Propranolol treatment of thyrotoxicosis in a premature infant. Br Med J 2:738.
84. 4. J Clin Endocrinol Metab 42:976-978.
85. Felber J-P, Reddy WJ, Selenkow HA, Thoen GW 1959 Adrenal cortical response of the 48-hour ACTH tests in myxedema and hyperthyroidism. J Clin Endocrinol Metab 19:895.
86. Vogt P, Stolz W, Landthler M 1995 Aplasia cutis congenita after exposure to methimazole. A causal realtionship? Br J Dermatol 133:994-996.
87. Mandel FJ, Brent GA, Larsen PR 1994 Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis. Thyroid 4:129-133.
88. Jansson R, Dahlberg PA, Lindstom B 1983 Comparative bioavailability of carbimazole and methimazole. J Clin Pharmacol Ther Toxicol 21:505-510.
89. Momotani N, Ito K, Hamata N 1984 Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol 20:695-700.
90. Van Dijke CP, Heydendael RJ, DeKleine MK 1987 Methimazole, carbimazole, and congenital skin defects. Ann Intern Med 106:60-61.
91. Martínez-Frías ML, Cereijo A, Rodríduez-Pinilla E, Urioste M 1992 Methimazole in animal feed and congenital aplasia cutis. Lancet 339:742-743.
92. Greenburg F 1987 Brief clinical report - Choanal atresia and athelia: Methimazole teratogenicity or a new syndrome? Am J Med Genet 28:931-934.
93. Wilson LC, Ker BA, Wilkinson R, Fossard C, Donnai D 1998 Choanal atresia and hypothelia following methimazole exposure in utero: A second report. Am J Med Genet 75:220-222.
94. Johnson E, Larson G, Ljunggren M 1997 Severe malformation in infant born to hyperthyroid woman on methimazole. Lancet 350:1520.
95. Ramirez A, Espinosa De Los Monteros A, Parra A, De Leon B 1992 Esophageal atresia and tracheoesophageal fistula in two infants born to hyperthyroid women receiving methimazole during pregnancy. Am J Med Genet 44:200-202.
96. Cheron RG, Kaplan MM, Larsen PR, Selenkow HA, Crigler JF Jr 1981 Neonatal thyroid function after propylthiouracil therapy for maternal Graves' disease. N Engl J Med 304:525-528.
97. Mestman JH 1997 Hyperthyroidism in pregnancy. Clin Obstet Gynecol 40:45-64.
98. De Groot LJ, Larsen PR, Hennemann G 1996 The Thyroid and its Diseases. Churchill Livingstone, New York, p. 534.